In drug-target MR, we found that HMGCR inhibitors positively protected against total sepsis (1OR, 0.719 per SD reduction in LDL-C; 95% CI, 0.540–0.958; P = 0.024). The gene discussed is HMGCR; the disease is Sepsis.